VBIZF (Viva Biotech Holdings) Total Equity : $524.0 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Total Equity?

Viva Biotech Holdings's total equity for the quarter that ended in Jun. 2024 was $524.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Viva Biotech Holdings Total Equity Historical Data

The historical data trend for Viva Biotech Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Total Equity Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

574.50

614.41

517.05

516.50

524.16

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Equity	Get a 7-Day Free Trial											517.05	508.33	516.50	524.03	524.16

Viva Biotech Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Viva Biotech Holdings's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	1043.376	-	526.876
	=	516.5

Viva Biotech Holdings's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2024 )	-	Total Liabilities(Q: Jun. 2024 )
	=	989.717	-	465.686
	=	524.0

Viva Biotech Holdings Total Equity Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (OTCPK:VBIZF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

01873:Hong Kong VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.